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 Overwhelming post-splenectomy infection (OPSI) is 
a severe disease that can progress from flu-like 
disturbances to fulminant sepsis since patients who are 
asplenic are at an increased risk for infection and death 
from microorganisms. To prevent OPSI, several measures 
are essential and must begin before a scheduled surgery or 
just after an urgent splenectomy. One proposed 
prevention measure is to enhance partial surgery when it 
is possible [1].  Although the introduction of an adequate 
vaccination programme against incapsulated bacteria and 
oral penicillin prophylaxis have decreased the overall risk 
of OPSI, its mortality rate is about 50-70% within 48 
hours from onset.  
Considering that OPSI can develop in a very short 
time period and that its related mortality rate worsens with 
delayed or inadequate treatment, it is important for 
Haematologists, Anaesthesiologists and Emergency 
Physicians to be familiar with it. In this number of 
Translational Medicine, Serio and Co-workers [2] present 
a 12-year survey describing the management of this 
relatively rare disease. The Authors cleverly refer to the 
importance of an aggressive and properly targeted early 
treatment: according to dr Morgan and Tomich [3] 
intensive care manoeuvres, including empiric antibiotics, 
and early goal-directed therapy, are the keys to successful 
treatment and if initiated early in the patient’s course, the 
70% mortality rate can be significantly reduced. 
Dr Serio et Al considerations about OPSI may be 
cautiously enlarged to the population of patients affected 
by malignancies of the lymphatic system or other 
tumours, who underwent chemotherapy. Infections in 
patients under immunosuppression, additionally enhanced 
by chemotherapy, often lead to the development of severe 
sepsis, associated with high mortality. Severe sepsis is 
currently defined as the presence of SIRS (systemic 
inflammatory response syndrome), a source of infection, 
and dysfunction of at least one vital organ [4]. 
Appropriate treatment includes detection and elimination 
of the source of infection as well as supporting organ 
function by maintaining tissue perfusion. State of the art 
therapy is summarized in the recently updated Surviving 
Sepsis Campaign (SSC) guidelines [5]. The clinical goals 
of the evidence-based bundled strategies include 
optimizing timeliness in the delivery of care and creating 
a continuum for sepsis management that runs from the 
emergency department to the acute and critical care 
settings. 
The course of sepsis is rapid. Patient outcomes 
improve when sepsis is diagnosed and treated quickly. 
OPSI and all the infection in hematologic malignancies 
patients are devastating: implementing the SSC guideline 
through an education programme is feasible and may 
result in early therapy (within 6 hours) with aggressive 
fluid administration and appropriate antibiotics, with 
relevant positive, impact on the outcome.  
 I wish that a Sepsis Education Programme may be 
implemented in every hospital, starting from teaching 
hospitals where early and correct therapeutic interventions 
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